edaravone 21 MG/ML Oral Suspension
RxNorm concept 2602117, clinical drug (scd). Prescribable name: edaravone 21 MG/mL Oral Suspension.
- RxCUI
- 2602117
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2602117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
edaravone 1050 MG per 50 ML Oral Suspension; edaravone 735 MG per 35 ML Oral Suspension
Related concepts
- edaravone 21 MG/ML (SCDC, consists of)
- Oral Suspension (DF, has dose form)
- edaravone 21 MG/ML Oral Suspension [Radicava] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2602117 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2602117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2602117. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.